Fundraising Fox

Vivodyne

Brisbane, US · Founded 2020 · Delaware corporation · 5 known investors

vivodyne.com ↗

Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development. The platform produces high-resolution phenomic, transcriptomic, and proteomic data from human tissue models to enable drug discovery and development.

AI & Machine LearningBiotechDeep Techin /vivodyne@vivodyne

Founders & leadership

JO
Julie O'ShaughnessyDirector
AG
Andrei GeorgescuExecutive Officer, Director
QS
Quinten StevensDirector
AA
Alex AndrianopolousDirector
DH
Dongeun HuhExecutive Officer, Director
AA
ALEX ANDRIANOPOULOSDirector
AM
Alex MorganDirector

Investors · 5

Bison VenturesSeattle
Kairos Venture Investments, LlcBeverly Hills · $150K – $20M
Khosla VenturesMenlo Park · $5K – $50Mvia Alex Morgan · board
Fortius VenturesreportedOrinda
MBX CapitalreportedClaymont · $250K – $2.5M

Reported raises · per SEC filings

Form D private placements
▶$77.7MraisedJun 2025 · 18 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie O'ShaughnessyDirector
  • Andrei GeorgescuExecutive Officer, Director
  • Quinten StevensDirector
  • Alex AndrianopolousDirector
  • Dongeun HuhExecutive Officer, Director
  • Alex MorganDirector
Offering amount
$77.7M
Amount sold
$77.7M
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMar 2021 · 1 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • ANDREI GEORGESCUExecutive Officer, Director
  • DONGEUN HUHExecutive Officer, Director
  • ALEX ANDRIANOPOULOSDirector
Offering amount
$4M
Amount sold
$2M
First sale
Mar 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news